[PLX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 32.83%
YoY- -90.84%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 6,358 2,889 2,081 4,670 1,769 679 -11,195 -
PBT 450 -59,148 -2,624 -7,290 -10,736 -8,526 -12,419 -
Tax 3,045 2,087 -189 268 213 314 -85,260 -
NP 450 -59,148 -2,624 -7,290 -10,853 -8,598 72,900 -96.64%
Tax Rate -676.67% - - - - - - -
Total Cost 5,908 62,037 4,705 11,960 12,622 9,277 -84,095 -
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 7.08 -2,047.35 -126.09 -156.10 -613.51 -1,266.27 -651.18 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS 0.04 -4.75 -0.21 -0.07 -0.11 -0.09 7.31 -96.90%
EPS Diluted -0.60 -4.75 -0.21 -0.07 -0.11 -0.09 7.31 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.